Blog
RSS FeedPosted by Michael Wonder on 09 Jul 2018
CADTH publishes final CDEC recommendation for dupilumab
9 July 2018 - CADTH has completed its assessment of Dupixent (dupilumab) for the treatment of patients with atopic dermatitis. ...
Posted by Michael Wonder on 09 Jul 2018
SMC rejects ocrelizumab (Ocrevus) for relapsing remitting MS in Scotland
9 July 2018 - The MS Trust is very disappointed that the Scottish Medicines Consortium is unable to recommend ocrelizumab as ...
Posted by Michael Wonder on 09 Jul 2018
NHS England says yes to Roche's Hemlibra
9 July 2018 - Roche’s new haemophilia A treatment Hemlibra has gained a valuable market access approval from NHS England. ...
Posted by Michael Wonder on 09 Jul 2018
How millennials' choices are reshaping private health insurance for everyone
10 July 2018 - Young people are deserting private hospital insurance by the thousands — and their decisions will have ...
Posted by Michael Wonder on 09 Jul 2018
SMC - July 2018 decisions
9 July 2018 - The SMC, which advises NHSScotland on newly licensed medicines, has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 09 Jul 2018
Vertex, NHS England no closer to Orkambi settlement
9 July 2018 - Vertex and NHS England remain locked in a battle over the provision of cystic fibrosis drug ...
Posted by Michael Wonder on 09 Jul 2018
PAH patients in England denied access to Actelion’s Uptravi on NHS
9 July 2018 - Actelion’s Uptravi will not be funded on the NHS for patients with pulmonary arterial hypertension, after ...
Posted by Michael Wonder on 08 Jul 2018
Notification of dates for entecavir brand switch
9 July 2018 - PHARMAC has announced the listing date and transition timeframes for a brand switch for entecavir from ...
Posted by Michael Wonder on 08 Jul 2018
CADTH publishes initial pERC recommendation for Roche's alectinib hydrochloride
6 July 2018 - The outcome relates to the use of alectinib hydrochloride (Alecensaro) for the first-line treatment of patients ...
Posted by Michael Wonder on 08 Jul 2018
ACT cancer patients have been slugged with an unfair fee. Until now.
3 July 2018 - The ACT Government has promised to scrap the chemotherapy co-payment ACT cancer patients are "unfairly" slugged ...
Posted by Michael Wonder on 08 Jul 2018
Life-changing Batten disease drug gives hope to children affected by fatal illness
8 July 2018 - As Tom Strahan runs after his big brother Jack, he shows the same desperation to keep ...
Posted by Michael Wonder on 07 Jul 2018
Dispensing disruption: are pharmacies ready for digital rivals?
7 July 2018 - When Amazon announced its purchase last week of online pharmacy PillPack, which packages and delivers pre-sorted ...
Posted by Michael Wonder on 06 Jul 2018
Decision to widen access and change the funded enzyme replacement therapy for Gaucher disease
6 Jul 2018 - PHARMAC is pleased to announce changes to the funding of enzyme replacement therapy used in the ...
Posted by Michael Wonder on 06 Jul 2018
Agenda for July 11 TC meeting
5 July 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 05 Jul 2018
Vertex calls NHS England ‘outrageous’ as Orkambi talks stall again
5 July 2018 - Public row about confidential pricing talks drags on. ...